Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is -1.51% vs 7.47% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -18.80% vs 51.98% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -6.26% vs 9.68% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -16.67% vs 65.52% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
Compare Quarterly Results Of SCHOTT Pharma AG & Co. KGaA With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 3.21% vs -2.99% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -1.51% vs 7.47% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -6.61% vs -1.19% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -18.80% vs 51.98% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -2.83% vs 0.67% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -6.26% vs 9.68% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 0.00% vs -27.27% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -16.67% vs 65.52% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






